Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diverse, Biologically Relevant, and Targetable Gene Rearrangements in Triple-Negative Breast Cancer and Other Malignancies
Timothy M. Shaver, Brian D. Lehmann, J. Scott Beeler, et al.
Cancer Research (2016) Vol. 76, Iss. 16, pp. 4850-4860
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Genetic Markers in Triple-Negative Breast Cancer
Zuzana Sporikova, Vladimíra Koudeláková, Radek Trojanec, et al.
Clinical Breast Cancer (2018) Vol. 18, Iss. 5, pp. e841-e850
Open Access | Times Cited: 229
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach
Marco Presta, Paola Chiodelli, Arianna Giacomini, et al.
Pharmacology & Therapeutics (2017) Vol. 179, pp. 171-187
Closed Access | Times Cited: 183
FGFR-TACC gene fusions in human glioma
Anna Lasorella, Marc Sanson, Antonio Iavarone
Neuro-Oncology (2016), pp. now240-now240
Open Access | Times Cited: 123
TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR+ Metastatic Triple-Negative Breast Cancer
Brian D. Lehmann, Vandana G. Abramson, Melinda E. Sanders, et al.
Clinical Cancer Research (2019) Vol. 26, Iss. 9, pp. 2111-2123
Open Access | Times Cited: 120
Key Roles of AXL and MER Receptor Tyrosine Kinases in Resistance to Multiple Anticancer Therapies
Marie Schoumacher, Mike F. Burbridge
Current Oncology Reports (2017) Vol. 19, Iss. 3
Open Access | Times Cited: 113
The local immune landscape determines tumor PD-L1 heterogeneity and sensitivity to therapy
Wei Yuan, Qiyi Zhao, Zhiliang Gao, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 8, pp. 3347-3360
Open Access | Times Cited: 104
Obesity and Triple-Negative Breast Cancer
Eric C. Dietze, Tanya Chavez, Victoria L. Seewaldt
American Journal Of Pathology (2017) Vol. 188, Iss. 2, pp. 280-290
Open Access | Times Cited: 92
Future applications of FGF/FGFR inhibitors in cancer
Gaia C. Ghedini, Roberto Ronca, Marco Presta, et al.
Expert Review of Anticancer Therapy (2018) Vol. 18, Iss. 9, pp. 861-872
Closed Access | Times Cited: 89
Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple-Negative Breast Cancer
Hui Liu, Charles J. Murphy, Florian A. Karreth, et al.
Cancer Discovery (2017) Vol. 8, Iss. 3, pp. 354-369
Open Access | Times Cited: 70
Triple-Negative Breast Cancer
Jonathan D. Marotti, Francine B. de Abreu, Wendy A. Wells, et al.
American Journal Of Pathology (2017) Vol. 187, Iss. 10, pp. 2133-2138
Open Access | Times Cited: 69
Axl inhibitors as novel cancer therapeutic agents
Yingying Shen, Xiguang Chen, Jun He, et al.
Life Sciences (2018) Vol. 198, pp. 99-111
Closed Access | Times Cited: 66
FGFR3 signaling and function in triple negative breast cancer
Nicole J. Chew, Elizabeth V. Nguyen, Shih‐Ping Su, et al.
Cell Communication and Signaling (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 63
MicroRNA in breast cancer: The association with BRCA1/2
Nina Petrović, Radoslav Davidović, Vladan Bajić, et al.
Cancer Biomarkers (2017) Vol. 19, Iss. 2, pp. 119-128
Closed Access | Times Cited: 51
Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived models
Nicole J. Chew, Terry C.C. Lim Kam Sian, Elizabeth V. Nguyen, et al.
Breast Cancer Research (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 33
KLF11/TMEM87B promoted the occurrence of glioma and decreased TMZ sensitivity
Jian Li, Hongliang Zong, Xiaoli Zhao, et al.
Cellular Signalling (2025), pp. 111651-111651
Closed Access
Targeting the TAM Receptors in Leukemia
Madeline G. Huey, Katherine A. Minson, H. Shelton Earp, et al.
Cancers (2016) Vol. 8, Iss. 11, pp. 101-101
Open Access | Times Cited: 34
Systemic Therapy for Metastatic Triple Negative Breast Cancer: Current Treatments and Future Directions
Laura Morrison, Alicia Okines
Cancers (2023) Vol. 15, Iss. 15, pp. 3801-3801
Open Access | Times Cited: 10
Landscape analysis of adjacent gene rearrangements reveals BCL2L14–ETV6 gene fusions in more aggressive triple-negative breast cancer
Sang Hoon Lee, Yiheng Hu, Suet Kee Loo, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 18, pp. 9912-9921
Open Access | Times Cited: 24
Structure of the GOLD-domain seven-transmembrane helix protein family member TMEM87A
Christopher Hoel, Lin Zhang, Stephen G. Brohawn
eLife (2022) Vol. 11
Open Access | Times Cited: 14
Development and validation of a novel clinical fluorescence in situ hybridization assay to detect JAK2 and PD-L1 amplification: a fluorescence in situ hybridization assay for JAK2 and PD-L1 amplification
Meixuan Chen, Mariacarla Andreozzi, Barbara A. Pockaj, et al.
Modern Pathology (2017) Vol. 30, Iss. 11, pp. 1516-1526
Open Access | Times Cited: 24
Diffuse Gliomas with FGFR3-TACC3 Fusions: Oncogenic Mechanisms, Hallmarks, and Therapeutic Perspectives
Alberto Pïcca, Giulio Sansone, Orazio Santo Santonocito, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5555-5555
Open Access | Times Cited: 6
Association between obesity with disease-free survival and overall survival in triple-negative breast cancer
Mei Lin, Lin He, Yuhua Song, et al.
Medicine (2018) Vol. 97, Iss. 19, pp. e0719-e0719
Open Access | Times Cited: 19
TAM kinases as regulators of cell death
Sean M. Post, Michael Andreeff, Courtney D. DiNardo, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2021) Vol. 1868, Iss. 6, pp. 118992-118992
Open Access | Times Cited: 15
Targeted and immuno-biology driven treatment strategies for triple-negative breast cancer: current knowledge and future perspectives
Carlo Fremd, Dirk Jaeger, Andreas Schneeweiß
Expert Review of Anticancer Therapy (2018) Vol. 19, Iss. 1, pp. 29-42
Closed Access | Times Cited: 17
MiRNAs: A Powerful Tool in Deciphering Gynecological Malignancies
Florentina Duică, Carmen Elena Condrat, Cezara Alina Dănilă, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top